Results 241 to 250 of about 84,964 (303)
Efficacy and Short-term Durability of Combined Botulinum Toxin Type A and Rehabilitation for Chronic Facial Asymmetry After Facial Nerve Palsy. [PDF]
Yamashita A, Miyanaga T, Yamashita M.
europepmc +1 more source
Gut mucin fucosylation dictates the entry of botulinum toxin complexes. [PDF]
Amatsu S +12 more
europepmc +1 more source
Ultrasound Evaluation of Upper Facial Muscles to Guide Botulinum Toxin Application. [PDF]
Jaguś D, Pawłowska A, Mlosek RK.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2020
Clostridium botulinum is an anaerobic, gram-positive bacterium that secretes an extremely large neurotoxic molecule (900 kDa), which produces food poisoning or botulism. It is now also used in medicine to treat diseases according to Paracelsus's paradigm that the difference between a poison and a drug lies in the dose.
Signorini, Massimo +5 more
openaire +2 more sources
Clostridium botulinum is an anaerobic, gram-positive bacterium that secretes an extremely large neurotoxic molecule (900 kDa), which produces food poisoning or botulism. It is now also used in medicine to treat diseases according to Paracelsus's paradigm that the difference between a poison and a drug lies in the dose.
Signorini, Massimo +5 more
openaire +2 more sources
Neurologic Clinics, 1991
Botulinum toxin therapy has emerged as a treatment modality for a variety of spastic- or contracture-related muscle diseases. Its safety has been proven for long-term use in the treatment of benign essential blepharospasm, hemifacial spasm, and certain types of strabismus. Recent approval from the Federal Drug Administration should make botulinum toxin
P J, Savino, M, Maus
openaire +2 more sources
Botulinum toxin therapy has emerged as a treatment modality for a variety of spastic- or contracture-related muscle diseases. Its safety has been proven for long-term use in the treatment of benign essential blepharospasm, hemifacial spasm, and certain types of strabismus. Recent approval from the Federal Drug Administration should make botulinum toxin
P J, Savino, M, Maus
openaire +2 more sources
Critical Care Clinics, 2005
Botulinum toxin is regarded as the most lethal substance known. It is estimated that the human LD50 for inhalation botulism is 1 to 3 nanograms of toxin/kilogram body mass. Although only three cases of inhalational botulism have been described, an understanding of the pathophysiology of food-borne outbreaks, wound botulism, and infant botulism, and ...
openaire +2 more sources
Botulinum toxin is regarded as the most lethal substance known. It is estimated that the human LD50 for inhalation botulism is 1 to 3 nanograms of toxin/kilogram body mass. Although only three cases of inhalational botulism have been described, an understanding of the pathophysiology of food-borne outbreaks, wound botulism, and infant botulism, and ...
openaire +2 more sources
Clinics in Dermatology, 2003
Botulinum toxin type A (BOTOX, Dysport) has revolutionized treatment of wrinkles around the eyes. Since the first publications of its cosmetic benefit by Drs. Jean and Alastair Carruthers, hundreds of articles have been published about its cosmetic use. BOTOX holds U.S.
openaire +2 more sources
Botulinum toxin type A (BOTOX, Dysport) has revolutionized treatment of wrinkles around the eyes. Since the first publications of its cosmetic benefit by Drs. Jean and Alastair Carruthers, hundreds of articles have been published about its cosmetic use. BOTOX holds U.S.
openaire +2 more sources
International Journal of Food Microbiology, 1990
Abstract Structure, activation, destruction, lethality, genesis, neurotoxic action and medical application of botulinal toxins are reviewed.
openaire +2 more sources
Abstract Structure, activation, destruction, lethality, genesis, neurotoxic action and medical application of botulinal toxins are reviewed.
openaire +2 more sources

